Maxime Teremetz, Ph.D. is a Co-Founder and Chief Science Officer at DEXTRAIN. He received his Ph.D. in Neuroscience from Paris City University. His clinical interests are Neurophysiology, Physiology, Stroke, Neuroimaging, Stroke Rehabilitation, Movement Disorders, Transcranial Magnetic Stimulation, Neuroscience, Brain Stimulation, and Stroke Imaging.